Recent studies have shown that the biallelic CEBPA mutations in AML do not appear to modify prognostic, but the coexistence with other chromosomal abnormalities and gene mutations may influence prognostic [31]. The gene discussed is CEBPA; the disease is acute myeloid leukemia.